BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210426
DTEND;VALUE=DATE:20210428
DTSTAMP:20260515T172517
CREATED:20201124T092500Z
LAST-MODIFIED:20201124T092658Z
UID:28055-1619395200-1619567999@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes East Coast 2021
DESCRIPTION:SMi are proud to announce the 8th Pre-filled Syringes East Coast virtual conference taking place on 26th and 27th April 2021. \nThe global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry\, is expected to exceed $9.7 billion by 2025. With that in mind\, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation\, new digital technology trends\, human studies and innovative design and delivery systems within the prefilled syringe industry. \nThis comprehensive overview will help attendees understand the changing global market and the challenges faced within the industry. The upcoming conference will cover key topics driving the industry including advancing development for drug delivery devices\, regulatory updates including the FDA draft guidance on bridging studies\, connectivity and digital health for combination products and compatibility for drug delivery systems. \nThis two-day agenda offers you peer-to-peer networking with Global Product Managers\, Senior PFS Engineers\, Device Testing Managers\, Heads of Late-Stage PFS Development and many more. \nWe look forward to welcoming you to the conference in April 2021. \n \nWho should attend: \n\nDrug-delivery developers\nMedical Device Engineers\nPrimary Packaging material designers\nSecondary packagers\nSmart device developers\nTraining device developers\nDevice-safety solution providers\nDrug developers\n\nTo register or for more information visit: www.pfsamericas.com/pjwl \nBenefit of attending:  \nPre-Filled Syringes East Coast will explore the latest industry updates on pre-filled syringes exploring considerations for platforms and integrated development. Gain insights into how the industry has overcome challenges of the pandemic with case studies on human factors studies and the acceleration towards connectivity for delivery devices. Hear from leading industry and regulatory experts on life cycle management\, guidance on bridging studies and biocompatibility considerations. \nThe SMi Virtual Conference Platform will deliver the following benefits: \n\nLive and On Demand speaker content: Get access to the latest strategies and case studies from your marketplace online!\nNetwork with all the event attendees: Connect\, see who’s attending\, chat and share contact details with all online delegates\, speakers and sponsors\nExhibit a Virtual Booth: You can pack your customized booth full of documents\, videos and even show who is manning the booth during the event and hosting meetings\nHost & Join Meetings & Socials: Join preferred speaking sessions\, host you own meetings and even a virtual Networking social\, with in built Zoom functionality\n\nAdditional Contact Info:\nT: +44 (0)20 7827 6088\nE: hsidhu@smi-online.co.uk\nTwitter: @SMiPharm #Smipfsusa\nLinkedIn: follow our company page – search ‘SMi Pharma’
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-east-coast-2021/
LOCATION:Virtual conference: Online access only
ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210426
DTEND;VALUE=DATE:20210429
DTSTAMP:20260515T172517
CREATED:20210208T084959Z
LAST-MODIFIED:20210208T084959Z
UID:28858-1619395200-1619654399@www.pharmajournalist.com
SUMMARY:Strategic Operational Excellence in Life Sciences
DESCRIPTION:Strategic Operational Excellence in Life Sciences is a brand new forum\, designed for and by strategic operations and operational excellence leaders in the Life Sciences\, with a vision to create a holistic\, enterprise-wide dialogue around business excellence innovation\, to ultimately redefine operational excellence as a competitive advantage for the modern scientific organization. \nIt will shine a light on the boldest operational excellence leaders from the most admired biopharma and medical devices businesses\, sharing their stories of process excellence innovation\, nurturing cultures of continuous improvement and re-examining supply chain operations during and beyond Covid-19. \nTo know more about Strategic Operational Excellence in Life Sciences please click here.
URL:https://www.pharmajournalist.com/event/strategic-operational-excellence-in-life-sciences/
LOCATION:Exclusive Virtual Conference
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210430
DTSTAMP:20260515T172517
CREATED:20210115T080512Z
LAST-MODIFIED:20210115T080512Z
UID:28488-1619481600-1619740799@www.pharmajournalist.com
SUMMARY:Interstitial Lung Disease Drug Development Summit
DESCRIPTION:Network with over 50 other industry pioneers including Ionis Pharmaceuticals\, Genentech\, Vicore and AnaMar to hear first-hand how the latest scientific research is innovating and upgrading ILD therapeutics at this trailblazing new meeting. \n \nThe 1st Interstitial Lung Disease Drug Development Summit is a ground-breaking new conference dedicated to helping you drive forward the development of effective therapies for chronic fibrosing ILDs and achieve success in anti-fibrotic drug development beyond IPF. \nVisit our website to download our event guide.
URL:https://www.pharmajournalist.com/event/interstitial-lung-disease-drug-development-summit/
LOCATION:Virtual Conference
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210430
DTSTAMP:20260515T172517
CREATED:20210118T174336Z
LAST-MODIFIED:20210118T174336Z
UID:28564-1619481600-1619740799@www.pharmajournalist.com
SUMMARY:3rd Neuroimmunology Drug Development Summit
DESCRIPTION:As diverse programs are advancing towards the clinic\, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics. \n \nBuilding on the success of last year’s meeting\, the 3rd Neuroimmunology Drug Development Summit will uncover how leading companies in this emerging field are discovering immune-modulating targets and deploying immuno-neurology across clinical case studies. As we gather the best minds in this infant field we will put a spotlight on the latest key learnings across microglia\, astrocytes\, STING\, TREM2 and more to help pave the way to translating key technological and mechanistic insights towards the clinic. \nJoin this intimate\, industry led forum to not only learn from those pioneering the field\, but to network and build meaningful partnerships with 80+ neuroimmunology drug development experts. \nTo find out more and view the 2021 speaker line-up\, download the 2021 event guide.
URL:https://www.pharmajournalist.com/event/3rd-neuroimmunology-drug-development-summit/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210430
DTSTAMP:20260515T172517
CREATED:20210121T100547Z
LAST-MODIFIED:20210121T100547Z
UID:28587-1619481600-1619740799@www.pharmajournalist.com
SUMMARY:Mitochondria-Targeted Drug Development Digital Summit
DESCRIPTION:The Mitochondria-Targeted Drug Development Digital Summit is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring what’s next to help you accelerate your pipeline into the clinic. \nWith 20+ hours of content\, 2 interactive workshops and over 5 hours of networking with key industry leaders from Larimar Therapeutics\, Minovia Therapeutics\, Mitokinin and many more\, this comprehensive forum will completely focus on mitochondria-targeting drug development and the current challenges and opportunities in the field. \n \nMake this your 2021 must-attend meeting and network with 80+ senior CSOs\, CEOs\, research scientists\, academics and investors committed to targeting mitochondria to tackle challenges with Mitochondrial & Age-related Diseases. \nIn this focused summit\, you’ll learn from the field’s pioneers who’ll be sharing their experience in: \n\nExploring the role of mitochondrial dysfunction in age-related diseases & rare genetic mitochondrial diseases\nExamining early discovery and research findings\nEvaluating preclinical drug development and studies\nDiscovering the patient perspective to aid mitochondria-targeted drug development\nAssessing clinical development and showcasing current trials\nLessons learned from clinical trial design and how design can be improved to mitigate common challenges\nRealizing the use of gene therapy\, editing technology and innovation\n\nTo know more about Mitochondria-Targeted Drug Development Digital Summit please click here.
URL:https://www.pharmajournalist.com/event/mitochondria-targeted-drug-development-digital-summit/
LOCATION:Virtual Event
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR